The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Open accessAbstract
Immune exclusion predicts poor patient outcomes in multiple malignancies, including triple-negative breast cancer (TNBC)1. The extracellular matrix (ECM) contributes to immune exclusion2. However, strategies to reduce ECM abundance are largely ineffective or generate undesired outcomes3,4. Here we show that discoidin domain receptor 1 (DDR1), a collagen receptor with tyrosine kinase activity5, instigates immune exclusion by promoting collagen fibre alignment. Ablation of Ddr1 in tumours promotes the intratumoral penetration of T cells and obliterates tumour growth in mouse models of TNBC. Supporting this finding, in human TNBC the expression of DDR1 negatively correlates with the intratumoral abundance of anti-tumour T cells. The DDR1 extracellular domain (DDR1-ECD), but not its intracellular kinase domain, is required for immune exclusion. Membrane-untethered DDR1-ECD is sufficient to rescue the growth of Ddr1-knockout tumours in immunocompetent hosts. Mechanistically, the binding of DDR1-ECD to collagen enforces aligned collagen fibres and obstructs immune infiltration. ECD-neutralizing antibodies disrupt collagen fibre alignment, mitigate immune exclusion and inhibit tumour growth in immunocompetent hosts. Together, our findings identify a mechanism for immune exclusion and suggest an immunotherapeutic target for increasing immune accessibility through reconfiguration of the tumour ECM. In mouse models of triple-negative breast cancer, the extracellular domain of the collagen receptor DDR1 has a role in tumour defence against the immune system, by aligning collagen fibres to obstruct immune infiltration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · cited 1×
“For RNA-seq differential gene expression analysis, TopHat2 (v.2.1.0) 27 was used to map sequence reads to Mus musculus transcriptome (GRCm38/mm10).”
InfluentialTIMER2.0 for analysis of tumor-infiltrating immune cells
Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., Li, B., & Liu, X. S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa407 · Cited by 5,209
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0136-1 · Cited by 5,179
Self-citationRaudvere, U., Kolberg, L., Kuzmin, I., Arak, T., Adler, P., Peterson, H., & Vilo, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz369 · Cited by 5,045
Determining cell type abundance and expression from bulk tissues with digital cytometry
Newman, A. M., Steen, C. B., Liu, C. L., Gentles, A. J., Chaudhuri, A. A., Scherer, F., Khodadoust, M. S., Esfahani, M. S., Luca, B. A., Steiner, D., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0114-2 · Cited by 4,478
Pvclust: an R package for assessing the uncertainty in hierarchical clustering
Suzuki, R., & Shimodaira, H. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl117 · Cited by 2,451
Proteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Therapeutic Targeting of the Tumor Microenvironment
Bejarano, L., Jordāo, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,653
Salmon, H., Franciszkiewicz, K., Damotte, D., Dieu-Nosjean, M.-C., Validire, P., Trautmann, A., Mami-Chouaib, F., & Donnadieu, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45817 · Cited by 1,138
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
Chen, Y., Kim, J., Yang, S., Wang, H., Wu, C.-J., Sugimoto, H., LeBleu, V. S., & Kalluri, R. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.02.007 · Cited by 566
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
Gruosso, T., Gigoux, M., Manem, V. S. K., Bertos, N., Zuo, D., Perlitch, I., Saleh, S. M. I., Zhao, H., Souleimanova, M., Johnson, R. M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci96313 · Cited by 439
Kaur, A., Ecker, B. L., Douglass, S. M., Kugel, C. H., Webster, M. R., Almeida, F. V., Somasundaram, R., Hayden, J., Ban, E., Ahmadzadeh, H., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0193 · Cited by 418
Discoidin Domain Receptor Functions in Physiological and Pathological Conditions
(2014) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-800180-6.00002-5 · Cited by 395
Discoidin domain receptor tyrosine kinases: new players in cancer progression
Valiathan, R. R., Marco, M., Leitinger, B., Kleer, C. G., & Fridman, R. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9346-z · Cited by 383
Edwards, D. N., Ngwa, V. M., Raybuck, A. L., Wang, S., Hwang, Y., Kim, L. C., Cho, S. H., Paik, Y., Wang, Q., Zhang, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140100 · Cited by 377
Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S. I., Williamson, P., Harrington, K., Leitinger, B., & Sahai, E. (2011) · Nature Cell Biology · doi:10.1038/ncb2133 · Cited by 366
Discoidin Domain Receptor 1 Tyrosine Kinase Has an Essential Role in Mammary Gland Development
Vogel, W. F., Aszódi, A., Alves, F., & Pawson, T. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.8.2906-2917.2001 · Cited by 309
Gao, H., Chakraborty, G., Zhang, Z., Akalay, I., Gadiya, M., Gao, Y., Sinha, S., Hu, J., Jiang, C., Akram, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.009 · Cited by 246
Comprehensive Benchmarking and Integration of Tumor Microenvironment Cell Estimation Methods
Jiménez-Sánchez, A., Cast, O., & Miller, M. L. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3560 · Cited by 210
Re-definition of claudin-low as a breast cancer phenotype
Fougner, C., Bergholtz, H., Norum, J. H., & Sørlie, T. (2020) · Nature Communications · doi:10.1038/s41467-020-15574-5 · Cited by 177
Ambrogio, C., Gómez-López, G., Falcone, M., Vidal, A., Nadal, E., Crosetto, N., Blasco, R. B., Fernández-Marcos, P. J., Sánchez-Céspedes, M., Ren, X., et al. (2016) · Nature Medicine · doi:10.1038/nm.4041 · Cited by 176
Carafoli, F., Mayer, M. C., Shiraishi, K., Pecheva, M. A., Chan, L. Y., Nan, R., Leitinger, B., & Hohenester, E. (2012) · Structure · doi:10.1016/j.str.2012.02.011 · Cited by 118
Dunlap, S. M., Chiao, L. J., Nogueira, L., Usary, J., Perou, C. M., Varticovski, L., & Hursting, S. D. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0034 · Cited by 102
Gui, X., Deng, M., Song, H., Chen, Y., Xie, J., Li, Z., He, L., Huang, F., Xu, Y., Anami, Y., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0036 · Cited by 100
Self-citationErikson, A., Örtegren, J., Hompland, T., Davies, C. D. L., & Lindgren, M. (2007) · Journal of Biomedical Optics · doi:10.1117/1.2772311 · Cited by 99
Ligand‐induced shedding of discoidin domain receptor 1
Vogel, W. F. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02360-8 · Cited by 95
Tomko, L. A., Hill, R. C., Barrett, A. S., Szulczewski, J. M., Conklin, M. W., Eliceiri, K. W., Keely, P. J., Hansen, K. C., & Ponik, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31126-w · Cited by 86
Ray, A., & Provenzano, P. P. (2021) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2021.05.004 · Cited by 80
Interaction of Discoidin Domain Receptor 1 with Collagen type 1
Agarwal, G., Mihai, C., & Iscru, D. F. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.12.073 · Cited by 70
Takai, K., Drain, A. P., Lawson, D. A., Littlepage, L. E., Karpuj, M. V., Kessenbrock, K., Le, A. M., Inoue, K., Weaver, V. M., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.301366.117 · Cited by 69
Ruggeri, J. M., Franco-Barraza, J., Sohail, A., Zhang, Y., Long, D., Pasca di Magliano, M., Cukierman, E., Fridman, R., & Crawford, H. C. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.03.020 · Cited by 40 · cited 2×
“6h–j), which is likely to reflect a compensatory tumour response as previously reported in Ddr1 -KO mouse models 12,13,17 .”
Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells
Meng, W., Li, L., Xiong, W., Fan, X., Deng, H., Bett, A. J., Chen, Z., Tang, A., Cox, K. S., Joyce, J. G., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1051440 · Cited by 30
Self-citationWu, B., Sun, X., Yuan, B., Ge, F., Gupta, H. B., Chiang, H.-C., Li, J., Hu, Y., Curiel, T. J., & Li, R. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.42966 · Cited by 23
Self-citation
Cited by
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Self-citationTurning cold tumors hot: from molecular mechanisms to clinical applications
Zhang, J., Huang, D., Saw, P. E., & Song, E. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.010 · Cited by 534
The hallmarks of cancer immune evasion
Galassi, C., Chan, T. A., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 565
Metadata
- Authors
- Sun, X., Wu, B., Chiang, H.-C., Deng, H., Zhang, X., Xiong, W., Liu, J., Rozeboom, A. M., Harris, B. T., Blommaert, E., Gomez, A., Garcia, R. E., Zhou, Y., Mitra, P., Prevost, M., Zhang, D., Banik, D., Isaacs, C., Berry, D., Lai, C., Chaldekas, K., Latham, P. S., Brantner, C. A., Popratiloff, A., Jin, V. X., Zhang, N., Hu, Y., Pujana, M. A., Curiel, T. J., An, Z., & Li, R.
- Venue
- Nature
- Published
- 2021-11-03
- Volume
- 599
- Issue
- 7886
- Pages
- 673-678
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3210691815
- Cited by
- 401
- References
- 37
- FWCI
- 19.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.